Pharmaceutical Industry Information Portal

HomeTagsGSK

All posts by tag

GSK

SK bioscience has reached the final stage of development of Korea’s first COVID-19 vaccine

SK bioscienceSK bioscience and GSK announced submission of a biologics license application for SKYCovione™ a recombinant protein-based COVID-19 vaccine candidate adjuvanted with GSK’s pandemic...

GSK shows strong sales performance in the first quarter of 2022 – £9.8 billion

British pharmaceutical giant GSK (GSK.L) on Wednesday beat analysts' expectations for its first-quarter results and reaffirmed its 2022 forecast. Highlights Strong sales growth across Biopharma and...

GSK expands oncology product line by acquiring Sierra Oncology for $1.9 billion

GlaxoSmithKline plc and Sierra Oncology, Inc April 13th announced that the companies have entered into an agreement under which GSK will acquire Sierra Oncology,...

CureVac and GSK contract with German government enabling rapid availability of 80 million mRNA-based vaccine

CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), and GSK today announced that...

LifeMine and GSK sign cooperation agreement to search for small molecules

LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere, today announced a strategic R&D collaboration...

GSK halts phase III vaccine trial of respiratory virus in pregnant women

GlaxoSmithKline, a science-led global healthcare company, on Monday announced that the Company has decided to stop enrolment and vaccination in trials evaluating its potential...
spot_img

Expert Articles

spot_img